AbbVie announced the creation of a new global business, Allergan Aesthetics, an AbbVie company. Allergan Aesthetics will operate as a new global dedicated business with its own research and development function under the AbbVie umbrella and will include leading aesthetic products including, Botox Cosmetic, the Juvederm collection of dermal fillers, and CoolSculpting body contouring, among others. This global business will be led by Carrie Strom, currently senior vice president of U.S. medical aesthetics for Allergan. Upon completion of the Allergan acquisition, Strom will be named senior vice president of AbbVie and president of global Allergan Aesthetics. She will oversee the worldwide operations, along with an experienced team of current Allergan leaders, and report directly to Richard A. Gonzalez, chairman and CEO of AbbVie. "We are enthusiastic about the potential of the new AbbVie and continue to make significant progress on completing our acquisition of Allergan," says Gonzalez. "The announcement marks an important step forward in our plans to create the integrated global company. We are fortunate to have a leadership team with a deep breadth of both industry and company experience and we are excited to welcome the new Allergan leaders to our company."